Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 832 of 6351
-
New radioactive drug combo takes on hard-to-treat gut and pancreatic cancers
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of Lutetium (177Lu) Oxodotreotide Injection in subjects with advanced gastrointestinal pancreatic neuroendocrine tumors.
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a break from teclistamab be safe for myeloma patients?
Disease control Recruiting nowThis is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group (IMWG) response criteria, following 6 to 9 months of treatment with teclistamab, a B-cell maturation ant…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could immunotherapy before surgery spare facial features in skin cancer?
Disease control PausedA non-randomized two-cohort study of neoadjuvant Cemiplimab or neoadjuvant Cemiplimab plus Fianlimab (CF) in patients with basal cell carcinoma of the head and neck. Enrollment in the dual-therapy cohort will begin after completion of enrollment in the monotherapy cohort. Patient…
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a custom vaccine slow Alzheimer's? new trial begins
Disease control OngoingALZN002-01 is a first-in-human, randomized, double-blind, placebo-controlled, parallel-group, phase 1/2a study of autologous amyloid beta mutant peptide-pulsed dendritic cells (ALZN002) in subjects with mild-to-moderate dementia of the Alzheimer's type.
Phase 1/2 • Sponsor: Alzamend Neuro, Inc. • Aim: Disease control
Last updated Jun 26, 2026 13:08 UTC
-
Magnetic pulses may boost social skills in kids with autism
Symptom relief CompletedThis study is a prospective, multicenter, randomized, single-blind controlled trial to enroll 200 children with autism spectrum disorders (ASD). The investigators hope to further explore the effectiveness of accelerated continuous theta-burst stimulation (a-cTBS) over the left pr…
Phase 2/3 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a new drug calm the immune System's attack on blood cells?
Disease control OngoingThe goal of this clinical study is to evaluate povetacicept in adults with autoimmune cytopenias of immune thrombocytopenia, autoimmune hemolytic anemia, and cold agglutinin disease to determine if povetacicept is safe and potentially beneficial in treating these diseases. During…
Phase 1/2 • Sponsor: Alpine Immune Sciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can arm workouts boost oxygen use in lung disease?
Disease control CompletedSevere dyspnea, cough, fatigue, restrictive type ventilation disorder, decreased pulmonary function, impaired gas exchange, decreased cardiovascular function and exercise intolerance are frequently encountered findings in patients with interstitial lung disease. It was demonstrat…
Sponsor: Gazi University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could donor stem cells ease knee pain? new trial aims to find out
Disease control OngoingThis is a Phase III, double-blinded, placebo-controlled, multicenter study to investigate the efficacy and safety of a new study intervention, ELIXCYTE, compared to placebo (normal saline) in subjects with knee osteoarthritis. The primary hypothesis of the study is to demonstrate…
Phase 3 • Sponsor: UnicoCell Biomed CO. LTD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill could save eyes from melanoma surgery
Disease control OngoingNeoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma
Phase 2 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Two-Drug cocktail aims to tame stubborn Crohn's disease
Disease control CompletedA multicenter retrospective study evaluating the effectiveness and safety of ustekinumab combined with low-dose upadacitinib in patients with refractory Crohn's disease.
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a simple pill stabilize blood pressure after spinal cord injury?
Disease control Recruiting nowThe purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypot…
Phase 4 • Sponsor: James J. Peters Veterans Affairs Medical Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
A smarter way to hand out overdose reversal kits?
Prevention OngoingThe goal of this clinical trial is to compare the effectiveness of a multi-faceted implementation strategy, the Systems Analysis and Improvement Approach for Naloxone (SAIA-N), in syringe service programs (SSPs). The main questions it aims to answer are: * Does SAIA-N improve na…
Sponsor: RTI International • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
New hope for breast cancer patients with brain tumors: drug trial targets hard-to-treat spread
Disease control Recruiting nowDatopotamab-deruxtecan in triple-negative breast cancer patients with newly diagnosed or progressing brain metastases.
Phase 2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo therapy aims to slow advanced liver cancer
Disease control Recruiting nowThis is a multi-center randomized phase III clinical study of first-line intravenous FOLFOX plus Camrelizumab and apatinib versus HAIC-FOLFOX plus Camrelizumab and apatinib for BCLC C stage hepatocellular carcinoma.
Phase 3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy shows promise for rare, Tough-to-Treat leukemia
Disease control Recruiting nowThe prognosis of acute leukaemias of ambiguous lineage is poor. The effect of chemotherapy regimen and hematopoietic stem cell transplantation are still unclear. Therefore, we will explore new therapy to improve the remission rate of acute leukaemias of ambiguous lineage. Venetoc…
Phase 2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New cocktail of drugs hopes to tackle Hard-to-Treat colorectal cancer
Disease control OngoingColorectal cancer (CRC) is the fourth leading cause of cancer death worldwide, claiming approximately 900,000 lives annually. In China, CRC has become one of the top three most common cancers, with about 555,000 new cases and 286,000 deaths reported in 2020. For patients with ad…
Phase 1/2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Mother's immune cells could help fight severe CMV in newborns
Disease control Recruiting nowPatients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened. All patients will receive treatment with valganciclovir or ganciclovir. There is a safety run in with treatment with CMV CTLs …
Phase 2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
DNA fingerprinting could solve the mystery of unknown primary cancers
Diagnosis Recruiting nowThis study aims to initially utilize machine learning on pan-cancer DNA methylation data from public databases to construct a DNA methylation classification model (PaCIFiC-CUP, pan-cancer integrated fingerprinting classifier of CUP) for diagnosing various types of cancer, particu…
Sponsor: Sun Yat-sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Smart dosing could transform Crohn's treatment in kids
Disease control Recruiting nowApproximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children and adults with Crohn's disease. Physicians need better ways to inform decisions o…
Phase 2/3 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI reads heart scans to predict heart attacks
Diagnosis By invitation onlyThe goal of this observational study is to develop an automatic whole-process AI model to detect, quantify, and characterize plaques using coronary CT angiography in coronary artery disease patients. The main questions it aims to answer are: 1. Whether the AI model enables to de…
Sponsor: Jinling Hospital, China • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC